Reversal of EMT by Small-Molecule Inhibitors of TGF-β Type I and II Receptors: Implications for Carcinoma Treatment

Lacher, M. D., Korn, W. M., & Akhurst, R. J. (2008). Reversal of EMT by Small-Molecule Inhibitors of TGF-β Type I and II Receptors: Implications for Carcinoma Treatment. In Transforming Growth Factor-β in Cancer Therapy, Volume II (pp. 707–722). Humana Press. https://doi.org/10.1007/978-1-59745-293-9_43